Reaching a New Milestone:
$300,000 in Grant Money Awarded
Six years ago this month, we launched MOCC with the hope of making a difference.
Mucinous ovarian cancer represents a small fraction of ovarian cancer diagnoses — which is precisely the problem. It's rare enough that research dollars hardly ever find their way to it. Rare enough that many oncologists will see only a handful of cases in their entire careers. And rare enough that patients often feel like they are facing this disease alone.
At MOCC, we refuse to let "rare" mean "forgotten."
In six short years, that conviction has built a community. Comprised of newly diagnosed women, survivors, families, researchers, and clinicians, we are united by one belief: a rare disease deserves anything but rare attention.
With our latest grant award, we’ve reached a milestone: $300,000 in funding for research!